Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
iShares MSCI ACWI ETF
ACWI
$33.6B
| $4.38M | ﹤0.01% |
30,956
-77,532
| -71% | -$10.9M |
|
2302
Acadia Healthcare
ACHC
$2.95B
| $4.38M | ﹤0.01% |
308,396
+198,435
| +180% | +$3.75M |
|
2303
CALL
Arthur J. Gallagher & Co
AJG
$65.5B
| $4.37M | ﹤0.01% |
+16,900
| New | +$4.47M |
|
2304
PUT
State Street SPDR S&P Retail ETF
XRT
$643M
| $4.37M | ﹤0.01% |
+51,200
| New | +$4.3M |
|
2305
Nabors Industries
NBR
$1.33B
| $4.34M | ﹤0.01% |
79,883
+5,982
| +8% | +$292K |
|
2306
First Financial Bancorp
FFBC
$3.6B
| $4.33M | ﹤0.01% |
172,878
+32,465
| +23% | +$810K |
|
2307
Harmony Biosciences
HRMY
$2.24B
| $4.32M | ﹤0.01% |
115,474
+3,960
| +4% | +$130K |
|
2308
Nomad Foods
NOMD
$1.68B
| $4.32M | ﹤0.01% |
+345,251
| New | +$4.21M |
|
2309
PUT
Trip.com Group
TCOM
$28.3B
| $4.31M | ﹤0.01% |
60,000
| – | – |
|
2310
Viking Holdings
VIK
$47.3B
| $4.31M | ﹤0.01% |
60,336
-43,690
| -42% | -$2.79M |
|
2311
Mercury Insurance
MCY
$5.84B
| $4.31M | ﹤0.01% |
45,771
+7,090
| +18% | +$615K |
|
2312
CALL
Dutch Bros
BROS
$8.93B
| $4.3M | ﹤0.01% |
+70,300
| New | +$3.99M |
|
2313
Digital Turbine
APPS
$1.53B
| $4.3M | ﹤0.01% |
859,408
+14,517
| +2% | +$82.2K |
|
2314
HDFC Bank
HDB
$119B
| $4.28M | ﹤0.01% |
117,159
+27,399
| +31% | +$986K |
|
2315
TFI International
TFII
$12.1B
| $4.28M | ﹤0.01% |
41,422
-21,001
| -34% | -$1.95M |
|
2316
Evertec
EVTC
$1.91B
| $4.28M | ﹤0.01% |
147,138
+13,707
| +10% | +$407K |
|
2317
Teradata
TDC
$2.57B
| $4.28M | ﹤0.01% |
140,498
+51,993
| +59% | +$1.36M |
|
2318
Avnet
AVT
$7.87B
| $4.26M | ﹤0.01% |
88,701
-29,604
| -25% | -$1.46M |
|
|
MRP
2319
Millrose Properties Inc
MRP
$5.02B
| $4.26M | ﹤0.01% |
142,526
+102,161
| +253% | +$3.2M |
|
2320
TORM
TRMD
$3.01B
| $4.23M | ﹤0.01% |
216,196
+9,688
| +5% | +$205K |
|
2321
Idacorp
IDA
$8.16B
| $4.23M | ﹤0.01% |
33,420
-95,239
| -74% | -$12.4M |
|
2322
Addus HomeCare
ADUS
$2.2B
| $4.22M | ﹤0.01% |
39,333
+3,315
| +9% | +$381K |
|
2323
Enterprise Financial Services Corp
EFSC
$2.41B
| $4.22M | ﹤0.01% |
78,182
+13,689
| +21% | +$752K |
|
2324
Kennametal
KMT
$2.35B
| $4.22M | ﹤0.01% |
148,571
+10,719
| +8% | +$274K |
|
2325
BancFirst
BANF
$3.89B
| $4.22M | ﹤0.01% |
39,792
+8,809
| +28% | +$997K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.